Blessing Ometere Ayeni
Research Subjects
Blessing Ometere Ayeni has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Fortune Itoje Ebiala
Department of Microbiology, Faculty of Life Sciences, University Of Benin, Benin City, Edo State, Nigeria
1 shared publication - Kehinde Oluwafemi Fabiyi
Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN, USA
1 shared publication - Maryam Olayemi Bakare
Department of Medical Laboratory Sciences, APIN Public Health Initiatives, Abuja, FCT, NIGERIA
1 shared publication - Victor Olawale Bejide
Department of Medical Laboratory Sciences, General Hospital, Ikorodu, Lagos State, NIGERIA
1 shared publication - Vivian Ifeyinwa Eze
Department of Microbiology Services Laboratory Bacteriology, NHS Blood and Transplant, London, UK
1 shared publication
Latest Publications
- Open Access
- 13 March 2026
- Published by Modestum Ltd in Journal of Contemporary Studies in Epidemiology and Public Health
- Vol. 7 (1) , ep26012
Mapping and characterizing persistent HIV reservoirs in early-treated individuals: Implications for cure-focused interventions
Despite the transformative impact of antiretroviral therapy (ART), HIV persists in long-lived cellular and anatomical reservoirs that reignite viral replication when treatment is interrupted. Eliminating or durably suppressing these reservoirs remains the central challenge to achieving a cure. Individuals who initiate ART during acute or early infection provide a particularly informative model, as early intervention is generally associated with reduced reservoir size, limited viral diversification, preservation of immune function, and lower levels of inflammation. These features create a valuable biological window for interrogating the earliest events of reservoir seeding and persistence. Recent advances in reservoir mapping including high-sensitivity molecular assays, full-length proviral sequencing, single-cell multi-omics, and spatial imaging have enabled increasingly refined characterization of reservoir composition, cellular identity, clonal dynamics, and tissue distribution. Studies in early-treated cohorts have identified features such as simplified clonal architecture, higher relative inducibility of intact proviruses, and, in some individuals, an increased likelihood of post-treatment control. These insights are informing the development of cure-focused interventions ranging from latency reversal and immune-based strategies to gene-editing approaches and targeted drug delivery. Nonetheless, important challenges remain, including incomplete tissue sampling, assay sensitivity limitations, and uncertainty regarding which cellular and anatomical reservoirs most critically drive viral rebound. Integrative approaches combining multi-omics profiling, predictive biomarkers, and personalized therapeutic strategies will be essential for advancing toward durable ART-free remission.
- 13 March 2026
- Published by Modestum Ltd in Journal of Contemporary Studies in Epidemiology and Public Health
- Vol. 7 (1) , ep26012
Open AccessMapping and characterizing persistent HIV reservoirs in early-treated individuals: Implications for cure-focused interventions
Despite the transformative impact of antiretroviral therapy (ART), HIV persists in long-lived cellular and anatomical reservoirs that reignite viral replication when treatment is interrupted. Eliminating or durably suppressing these reservoirs remains the central challenge to achieving a cure. Individuals who initiate ART during acute or early infection provide a particularly informative model, as early intervention is generally associated with reduced reservoir size, limited viral diversification, preservation of immune function, and lower levels of inflammation. These features create a valuable biological window for interrogating the earliest events of reservoir seeding and persistence. Recent advances in reservoir mapping including high-sensitivity molecular assays, full-length proviral sequencing, single-cell multi-omics, and spatial imaging have enabled increasingly refined characterization of reservoir composition, cellular identity, clonal dynamics, and tissue distribution. Studies in early-treated cohorts have identified features such as simplified clonal architecture, higher relative inducibility of intact proviruses, and, in some individuals, an increased likelihood of post-treatment control. These insights are informing the development of cure-focused interventions ranging from latency reversal and immune-based strategies to gene-editing approaches and targeted drug delivery. Nonetheless, important challenges remain, including incomplete tissue sampling, assay sensitivity limitations, and uncertainty regarding which cellular and anatomical reservoirs most critically drive viral rebound. Integrative approaches combining multi-omics profiling, predictive biomarkers, and personalized therapeutic strategies will be essential for advancing toward durable ART-free remission.